SCHEMBL16237029

SCHEMBL16237029

Cc1[nH]c(C(=O)Nc2ccc(F)c(C(F)F)c2)cc1S(=O)(=O)Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ NPC1 O15118 6/20 0.40
▸ RAB9A P51151 6/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ PRNP P04156 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PYGL P06737 1/20 0.39
▸ PLA2G7 Q13093 4/20 0.38
▸ MAPT P10636 3/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ THRB P10828 1/20 0.38
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ RXFP1 Q9HBX9 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16237501 0.88 RAB9A (0.48) NPC1RAB9AALDH1A1KDM4EPRNP
SCHEMBL16236610 0.87 NPC1 (0.49) NPC1RAB9AALDH1A1KDM4EPRNP
SCHEMBL16237067 0.83 GRM4 (0.41) NPC1RAB9AALDH1A1KDM4EPRNP
SCHEMBL16237208 0.82 GRM4 (0.50) NPC1RAB9AALDH1A1KDM4EPRNP
SCHEMBL16237215 0.81 CYP1A2 (0.45) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL16236529 0.81 IDO1 (0.43) NPC1RAB9AALDH1A1KDM4EPRNP
SCHEMBL16236925 0.78 CYP1A2 (0.36) CYP1A2NPC1RAB9AALDH1A1KDM4E
SCHEMBL21623356 0.77 LMNA (0.51) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL16236340 0.77 ENPP2 (0.43) CYP1A2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL16237209 0.77 PLA2G7 (0.45) NPC1RAB9APLA2G7KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997011-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B Janssen Sciences Ireland UC (IE) 2016-03-23 — — EP disclosed
WO-2014184350-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B JANSSEN R&D IRELAND (IE) 2014-11-20 — — WO disclosed
Send feedback